Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Two cases of "cannabis acute psychosis" following the administration of oral cannabis.

Favrat B, Ménétrey A, Augsburger M, Rothuizen LE, Appenzeller M, Buclin T, Pin M, Mangin P, Giroud C.

BMC Psychiatry. 2005 Apr 1;5:17.

PMID:
15804348
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The effects of cannabinoids on serum cortisol and prolactin in humans.

Ranganathan M, Braley G, Pittman B, Cooper T, Perry E, Krystal J, D'Souza DC.

Psychopharmacology (Berl). 2009 May;203(4):737-44. doi: 10.1007/s00213-008-1422-2. Epub 2008 Dec 16.

PMID:
19083209
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Cannabis psychosis following bhang ingestion.

Chaudry HR, Moss HB, Bashir A, Suliman T.

Br J Addict. 1991 Sep;86(9):1075-81.

PMID:
1932878
[PubMed - indexed for MEDLINE]
4.

Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness.

Koethe D, Gerth CW, Neatby MA, Haensel A, Thies M, Schneider U, Emrich HM, Klosterkötter J, Schultze-Lutter F, Leweke FM.

Schizophr Res. 2006 Dec;88(1-3):142-50. Epub 2006 Sep 26.

PMID:
17005373
[PubMed - indexed for MEDLINE]
5.

Cannabinoid content of some English reefers.

Fairbairn JW, Hindmarch I, Simic S, Tylden E.

Nature. 1974 May 17;249(454):276-8. No abstract available.

PMID:
4833245
[PubMed - indexed for MEDLINE]
6.

What is the mechanism whereby cannabis use increases risk of psychosis?

Luzi S, Morrison PD, Powell J, di Forti M, Murray RM.

Neurotox Res. 2008 Oct;14(2-3):105-12. doi: 10.1007/BF03033802. Review.

PMID:
19073418
[PubMed - indexed for MEDLINE]
7.

The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis.

D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH.

Neuropsychopharmacology. 2004 Aug;29(8):1558-72.

PMID:
15173844
[PubMed - indexed for MEDLINE]
Free Article
8.

Cannabinoid concentrations in hair from documented cannabis users.

Huestis MA, Gustafson RA, Moolchan ET, Barnes A, Bourland JA, Sweeney SA, Hayes EF, Carpenter PM, Smith ML.

Forensic Sci Int. 2007 Jul 4;169(2-3):129-36. Epub 2006 Sep 11.

PMID:
16963215
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans.

D'Souza DC, Pittman B, Perry E, Simen A.

Psychopharmacology (Berl). 2009 Mar;202(4):569-78. doi: 10.1007/s00213-008-1333-2. Epub 2008 Sep 21.

PMID:
18807247
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.

Ramaekers JG, Kauert G, Theunissen EL, Toennes SW, Moeller MR.

J Psychopharmacol. 2009 May;23(3):266-77. doi: 10.1177/0269881108092393. Epub 2008 Aug 21.

PMID:
18719045
[PubMed - indexed for MEDLINE]
11.

Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis.

Morgan CJ, Freeman TP, Schafer GL, Curran HV.

Neuropsychopharmacology. 2010 Aug;35(9):1879-85. doi: 10.1038/npp.2010.58. Epub 2010 Apr 28.

PMID:
20428110
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

[Brave new world: cannabis for all? Some psychiatric remarks].

Hambrecht M.

Psychiatr Prax. 2003 May;30(4):179-81. German. No abstract available.

PMID:
12768520
[PubMed - indexed for MEDLINE]
13.

Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.

Wachtel SR, ElSohly MA, Ross SA, Ambre J, de Wit H.

Psychopharmacology (Berl). 2002 Jun;161(4):331-9. Epub 2002 Apr 19.

PMID:
12073159
[PubMed - indexed for MEDLINE]
14.

Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol.

Levin FR, Mariani JJ, Brooks DJ, Xie S, Murray KA.

Drug Alcohol Depend. 2010 Jan 1;106(1):65-8. doi: 10.1016/j.drugalcdep.2009.07.021. Epub 2009 Sep 3.

PMID:
19733018
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence.

Cooper ZD, Haney M.

Int Rev Psychiatry. 2009 Apr;21(2):104-12. doi: 10.1080/09540260902782752. Review.

PMID:
19367504
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Adverse effects of cannabis.

[No authors listed]

Prescrire Int. 2011 Jan;20(112):18-23. Review.

PMID:
21462790
[PubMed - indexed for MEDLINE]
17.

Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis.

Khiabani HZ, Mørland J, Bramness JG.

Eur J Intern Med. 2008 Dec;19(8):608-12. doi: 10.1016/j.ejim.2007.06.031. Epub 2008 Apr 18.

PMID:
19046727
[PubMed - indexed for MEDLINE]
18.

Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms.

Budney AJ, Vandrey RG, Hughes JR, Moore BA, Bahrenburg B.

Drug Alcohol Depend. 2007 Jan 5;86(1):22-9. Epub 2006 Jun 12.

PMID:
16769180
[PubMed - indexed for MEDLINE]
19.
20.

Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.

Niedbala RS, Kardos KW, Fritch DF, Kunsman KP, Blum KA, Newland GA, Waga J, Kurtz L, Bronsgeest M, Cone EJ.

J Anal Toxicol. 2005 Oct;29(7):607-15.

PMID:
16419389
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk